Access Vascular, Inc. — Form D
Access Vascular, Inc. of BEDFORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-30. The offering totals $31.6M, of which $20.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-10-30
- Form: D
- Accession: 0001080368-23-000040
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $31.6M
- Amount sold: $20.6M
- Remaining: $10.9M
- Minimum investment: $8K
- Investors: 19
- Date of first sale: 2023-10-13
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-495942
Issuer
- Name: Access Vascular, Inc.
- CIK: 0001714846
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 175 MIDDLESEX TURNPIKE, SUITE 1A, BEDFORD, MA, 01730
- Phone: 781-538-6594
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Amine R Bentaleb | Director | Bedford, MA |
| Michael R Jaff | Director | Bedford, MA |
| Luc R Marengere | Director | Bedford, MA |
| JJ Pelligrino | Director | Bedford, MA |
| Marc R Riviere | Director | Bedford, MA |
| Brent Sabin | Director | Bedford, MA |
| James Biggins | Executive Officer | Bedford, MA |
| James Biggins | Director | Bedford, MA |
| Paul Sabin | Director | Bedford, MA |
| Brent Ratz | Director | Bedford, MA |
| Alexandra R MacLean | Director | Bedford, MA |
| Joseph Pellegrino | Director | Bedford, MA |
Other filings by this issuer (5)
More